There are four types ofpolycystic ovary syndrome: Insulin-resistant polycystic ovary syndrome,inflammatory polycystic ovary syndrome, hidden-cause polycystic ovary syndrome,and pill-induced polycystic ovary syndrome.
Statistics:
The global PolycysticOvary Syndrome Treatment Market is estimated to account for US$ 945.1 Mn interms of value and is expected to reach US$ 1,311.0 Mn by the end of 2027.
Global Polycystic Ovary SyndromeTreatment Market: Drivers
Increasing funding for R&D isexpected to propel growth of the global polycystic ovary syndrome treatmentmarket over the forecast period. For instance, in 2019, Wellcome Trust funded aUS$ 3 million project that observed 1,000 women suffering from polycystic ovarysyndrome in three studies including the testing of a new drug.
Global Polycystic Ovary Syndrome TreatmentMarket: Opportunities
Launch of branded products as adirect treatment for polycystic ovary syndrome is expected to offer lucrativegrowth opportunities for players in the global polycystic ovary syndrometreatment market. Currently, there are no drugs approved by FDA and EMA for thetreatment of polycystic ovary syndrome. Thus, drug manufacturers are beingpresented the opportunity to hold significant share in the market.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1589
Global Polycystic Ovary SyndromeTreatment Market: Restraints
Lower diagnosis rate inunderdeveloped economies is expected to hinder growth of the global polycysticovary syndrome treatment market. Awareness regarding polycystic ovary syndromeand its symptoms among populations in underdeveloped economies is significantlylow.
Key Takeaways:
The global polycystic ovarysyndrome treatment market was valued at US$ 904.7 Mn in 2019 and is forecast toreach a value of US$ 1,311.0 Mn by 2027 at a CAGR of 4.8% between 2020 and2027. Major factor driving the growth of global polycystic ovary syndrometreatment market during the forecast period include high prevalence ofpolycystic ovary syndrome, and research and development.
Insulin Sensitizing Agents helddominant position in the global polycystic ovary syndrome treatment market in2019, accounting for 32.9% share in terms of value, followed by AromataseInhibitors & SERMs and Oral contraceptives, respectively.
Market Trends
Increasing awareness regardingpolycystic ovary syndrome is expected to propel growth of the global polycysticovary syndrome treatment market. For instance, in September 2019, SIHFHealthcare, U.S. raised awareness of polycystic ovary syndrome on the occasionof Polycystic Ovary Syndrome (PCOS) Awareness Month.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/polycystic-ovarian-syndrome-treatment-market-1589
Moreover, R&D in polycysticovary syndrome is also expected to aid in growth of the market. For instance,in 2018, an international consortium, including researchers at the Icahn Schoolof Medicine at Mount Sinai, conducted a whole genome association study toidentify common genetic architecture for different diagnostic criteria used todefine polycystic ovary syndrome.
Global Polycystic Ovary SyndromeTreatment Market: Competitive Landscape
Major players operating in theglobal polycystic ovary syndrome treatment market include, Sanofi, Novartis AG,Teva Pharmaceutical Industries Limited, Addex Therapeutics Ltd., BIOCAD, MerckKGaA, AstraZeneca plc., Bristol Myers Squibb Co., Ferring Pharmaceuticals,Inc., and Crinetics Pharmaceuticals, Inc.
Global Polycystic Ovary SyndromeTreatment Market: Key Developments
Major players in the globalpolycystic ovary syndrome treatment market are focused on adopting M&Astrategies to expand their product portfolio. For instance, in August 2020,Bayer AG acquired U.K.-based KaNDy Therapeutics and its investigational treatmentfor menopause with a US$ 425 million upfront payment, in order to expand itswomen’s healthcare pipeline.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1589
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
